Skip to main content

Rein Therapeutics, Inc.

RNTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001420565

No open-market purchases or sales by Rein Therapeutics, Inc. insiders were filed in the last 90 days; 59 institutions reported holding it in 13F filings for Q2 2026, worth $42.3M in total; no superinvestor holds it.

13F holders, Q4 2025

Institutional positions in Rein Therapeutics, Inc. as of Dec 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
48
+9 vs. Q3 2025
Shares held
10.8M
+2.33M (+27.6%) vs. Q3 2025
Total value
$12.5M
+$2.84M (+29.2%) vs. Q3 2025
New holders
13
14 more added
Sold out
4
5 more reduced

1 institution that held it in Q3 2025 haven't filed for Q4 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q3 2025: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting RNTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ4 2025: 48 institutions
Q1 2021: 52 institutionsQ2 2021: 47 institutionsQ3 2021: 43 institutionsQ4 2021: 43 institutionsQ1 2022: 42 institutionsQ2 2022: 37 institutionsQ3 2022: 33 institutionsQ4 2022: 19 institutionsQ1 2023: 19 institutionsQ2 2023: 17 institutionsQ3 2023: 16 institutionsQ4 2023: 20 institutionsQ1 2024: 23 institutionsQ2 2024: 29 institutionsQ3 2024: 32 institutionsQ4 2024: 31 institutionsQ1 2025: 39 institutionsQ2 2025: 36 institutionsQ3 2025: 40 institutionsQ4 2025: 48 institutionsQ1 2026: 46 institutionsQ2 2026: 59 institutions
Value heldQ4 2025: $12.5M
Q1 2021: $48.0MQ2 2021: $41.5MQ3 2021: $33.6MQ4 2021: $18.9MQ1 2022: $16.5MQ2 2022: $8.34MQ3 2022: $5.86MQ4 2022: $3.21MQ1 2023: $1.30MQ2 2023: $1.83MQ3 2023: $1.59MQ4 2023: $3.24MQ1 2024: $11.0MQ2 2024: $13.5MQ3 2024: $16.3MQ4 2024: $13.1MQ1 2025: $10.6MQ2 2025: $9.30MQ3 2025: $9.76MQ4 2025: $12.5MQ1 2026: $14.8MQ2 2026: $42.3M
Institutions holding RNTX and their total value by quarter
QuarterHoldersValue
Q2 202659$42.3M
Q1 202646$14.8M
Q4 202548$12.5M
Q3 202540$9.76M
Q2 202536$9.30M
Q1 202539$10.6M
Q4 202431$13.1M
Q3 202432$16.3M
Q2 202429$13.5M
Q1 202423$11.0M
Q4 202320$3.24M
Q3 202316$1.59M
Q2 202317$1.83M
Q1 202319$1.30M
Q4 202219$3.21M
Q3 202233$5.86M
Q2 202237$8.34M
Q1 202242$16.5M
Q4 202143$18.9M
Q3 202143$33.6M
Q2 202147$41.5M
Q1 202152$48.0M

Institutions, Q4 2025

Shares, value and share of portfolio for each institution holding Rein Therapeutics, Inc.; share changes are against Q3 2025.

Institutions holding RNTX in Q4 2025
InstitutionSharesValue% of portfolioChange in sharesAction
Voss Capital, LLC4,243,969$4.92M0.26%+1,577,437+59.2%Added
BIOS Capital Management, LP1,690,751$1.96M2.37%00.0%Unchanged
Vanguard Group Inc1,165,807$1.35M0.00%−2,600−0.2%Reduced
University of Texas/Texas Am Investment Managment Co511,610$593.5K0.08%00.0%Unchanged
Prosight Management, LP442,600$513.4K0.11%−125,298−22.1%Reduced
Cable Car Capital LLC420,000$487.2K0.03%00.0%Unchanged
Geode Capital Management, LLC284,555$330.2K0.00%+37,244+15.1%Added
Texas Capital Bank Wealth Management Services Inc262,125$304.1K0.02%+235,954+901.6%Added
Sigma Planning Corp247,277$298.6K0.01%−6,550−2.6%Reduced
Gagnon Securities LLC240,220$278.7K0.06%+11,528+5.0%Added
Senvest Management, LLC230,895$267.8K0.01%00.0%Unchanged
ABS Direct Equity Fund LLC125,000$145.0K0.17%+125,000New
Citadel Advisors LLC120,083$139.3K0.00%+91,882+325.8%Added
Rock Creek Group, LP100,000$116.0K0.01%+100,000New
State Street Corp75,904$88.0K0.00%+59,900+374.3%Added
Jane Street Group, LLC61,960$71.9K0.00%+61,960New
Susquehanna International Group, LLP58,995$68.4K0.00%+28,135+91.2%Added
BlackRock, Inc.55,006$63.8K0.00%+2,132+4.0%Added
Northwestern Mutual Wealth Management Co42,440$49.2K0.00%00.0%Unchanged
Two Sigma Investments, LP41,709$48.4K0.00%+41,709New
Northern Trust Corp40,469$46.9K0.00%+14,706+57.1%Added
Chicago Partners Investment Group LLC31,048$42.5K0.00%00.0%Unchanged
HRT Financial LP33,237$38.0K0.00%+33,237New
Meridian Wealth Advisors, LLC28,486$33.0K0.00%00.0%Unchanged
Renaissance Technologies LLC22,700$26.3K0.00%+4,402+24.1%Added
Gleason Group, Inc.22,389$26.0K0.00%00.0%Unchanged
Ancora Advisors, LLC20,000$23.2K0.00%+20,000New
Global Retirement Partners, LLC19,316$22.4K0.00%+12,116+168.3%Added
KG&L Capital Management,LLC18,000$20.9K0.01%00.0%Unchanged
Cane Capital Partners, LLC18,000$20.9K0.01%+18,000New
Mercer Global Advisors Inc17,961$20.8K0.00%+7,500+71.7%Added
Americana Partners, LLC17,302$20.1K0.00%00.0%Unchanged
Two Sigma Securities, LLC17,254$20.0K0.00%+17,254New
Annandale Capital, LLC15,026$17.0K0.00%+15,026New
Virtu Financial LLC13,663$16.0K0.00%+13,663New
Cetera Investment Advisers12,364$14.3K0.00%00.0%Unchanged
HighTower Advisors, LLC10,000$11.6K0.00%+10,000New
UBS Group AG9,516$11.0K0.00%+9,433+11,365.1%Added
Rockefeller Capital Management L.P.5,097$5.91K0.00%00.0%Unchanged
New Millennium Group LLC2,038$2.36K0.00%+2,038New
Tower Research Capital LLC (TRC)1,957$2.27K0.00%−3,072−61.1%Reduced
JFS Wealth Advisors, LLC1,590$1.84K0.00%00.0%Unchanged
US Bancorp1,250$1.45K0.00%00.0%Unchanged
Advisor Group Holdings, Inc.70$810.00%+35+100.0%Added
Bank of America Corp42$490.00%−58−58.0%Reduced
Ronald Blue Trust, Inc.20$230.00%00.0%Unchanged
Acadian Asset Management LLC17$00.00%00.0%Unchanged
Motiv8 Investments LLC25$00.00%+25New
Exencial Wealth Advisors, LLC0$00.00%−30,528−100.0%Sold out
Blair William & Co0$00.00%−23,393−100.0%Sold out
XTX Topco Ltd0$00.00%−14,984−100.0%Sold out
Warberg Asset Management LLC0$00.00%−11,000−100.0%Sold out
KCK Ltd.––––Not filed